SCHEMBL13864449

SCHEMBL13864449

COCCCCC1(COC)CCCC1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.30
CYP4A11 Q02928 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13864364 0.85
SCHEMBL13864564 0.81
SCHEMBL7876253 0.80
SCHEMBL14129059 0.80 KDM4E (0.31)
SCHEMBL797967 0.80 CYP4F2 (0.31) CYP4F2CYP4A11
SCHEMBL13864442 0.77
SCHEMBL1245675 0.77
SCHEMBL6874593 0.76
SCHEMBL18035776 0.76 MMP2 (0.31)
SCHEMBL13864579 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009064975-A1 QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2009-05-22 WO disclosed